Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab.
Nat Commun. 2021 Dec 14;12(1):7280. doi: 10.1038/s41467-021-27574-0.
Nat Commun. 2021.
PMID: 34907192
Free PMC article.
Clinical Trial.